A Long-term Extension Study of PCI-32765 (Ibrutinib)
for Chronic Lymphocytic Leukemia
4 locations incl. Orange
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT01804686·Phase 3·Recruiting·Listed Mar 2013
Clinical research site in Columbus, Ohio · 915 OLENTANGY RIVER RD, SUITE 2100, COLUMBUS, OH 43212-3153 · (614) 293-8566
Part of Ohio State University
As of July 2026, 10 paid clinical trials are recruiting at The Ohio State University James Cancer Hospital in Columbus, Ohio. Active studies at this site cover conditions such as Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma and Mantle Cell Lymphoma. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .